AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimbio-G 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Bio Formulation

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimbio-G 1 Tablet PR

DiaGlyc-Duo, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This formulation combines two active ingredients to regulate blood glucose. Administer DiaGlyc-Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled glucose levels; abrupt cessation can lead to dangerously elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, DiaGlyc-Duo complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect. Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and implement appropriate countermeasures. Maintain regular meals and carry a quick-acting glucose source, like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. DiaGlyc-Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before starting this medication. Consult your physician before using DiaGlyc-Duo during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimbio-G 1 Tablet PR

Managing Type 2 Diabetes

Major Benefits of Glimbio-G 1 Tablet PR:

Follow your physician's instructions or refer to the package insert for dosage information. Take one Glimbio-G tablet with a meal.

Common Side effects of Glimbio-G 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimbio-G 1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Take Glimbio-G 1 Tablet PR with a meal.

How Glimbio-G 1 Tablet PR works:

Glimbio-G 1 PR tablet combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts triply: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimbio-G 1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimbio-G 1 Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimbio-G 1 Tablet PR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimbio-G 1 Tablet PR cautiously, potentially requiring dosage modification. Consult your physician. Glimbio-G 1 Tablet PR is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimbio-G 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically advised for those with mild to moderate liver disease; the medication is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimbio-G 1 Tablet PR :

For Glimbio-G 1 Tablet PR, take a missed dose promptly if you remember. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimbio-G 1 Tablet PR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimbio-G 1 Tablet PR

Retain this medication within its original, tightly sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Glimbio-G 1 Tablet PR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare adverse effect poses a significant risk to individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Glimbio-G 1 Tablet PR use and seek immediate medical attention.
Glimbio-G 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and enhances insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Glimbio-G 1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Serious, though infrequent, side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glimbio-G 1 Tablet PR administration can indeed lead to Vitamin B12 deficiency by disrupting its gastric absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum of once annually, has been proposed by some investigators.
Indeed, Glimbio-G 1 Tablet PR can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may encompass nausea, headache, irritability, increased hunger, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a rapidly absorbable sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimbio-G 1 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol consumption also elevates the likelihood of lactic acidosis.
Glimbio-G 1 Tablet PR
37
MRP 45
17% off